SR 142801, The first potent non-peptide antagonist of the tachykinin NK3 receptor-Reference-Cited by-同舟云学术

SR 142801, The first potent non-peptide antagonist of the tachykinin NK3 receptor

Published:1994-11 Issue:1 Volume:56 Page:PL27-PL32
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Emonds-Alt X.,Bichon D.,Ducoux J.P.,Heaulme M.,Miloux B.,Poncelet M.,Proietto V.,Van Broeck D.,Vilain P.,Neliat G.,Soubrie´ P.,Le Fur G.,Brele`ere J.C.

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference16 articles.

1. Neurokinin receptor subtypes characterized by biological assays

2. Tachykinin receptors and tachykinin receptor antagonists

3. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist

4. A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors;British Journal of Pharmacology;2021-09-16

2. Construction of Quaternary Carbon Center by Catalytic Asymmetric Alkylation of 3‐Arylpiperidin‐2‐ones Under Phase‐Transfer Conditions;Angewandte Chemie International Edition;2020-02-03

3. Introduction;Structure–Activity Relationships for Development of Neurokinin-3 Receptor Antagonists;2020

4. Construction of Quaternary Carbon Center by Catalytic Asymmetric Alkylation of 3‐Arylpiperidin‐2‐ones Under Phase‐Transfer Conditions;Angewandte Chemie;2019-12-23

5. Scaffold hopping of fused piperidine-type NK3 receptor antagonists to reduce environmental impact;Bioorganic & Medicinal Chemistry;2019-05